# US 9,902,942 B2 · Chromatographic purification of virus preparations with negatively charged particles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 9,902,942 B2
- Document ID: US9902942B2
- Status: Granted
- Kind: B2
- Application number: 14/768,213
- Filed: 2013-02-22
- Published: 2016-01-07
- Granted: 2018-02-27
- Earliest claimed: 2013-02-22
- Assignees: Agency for Science, Technology and Research
- Applicants: Agency for Science, Technology and Research
- Inventors: Peter Stanley Gagnon
- Web page: https://patentgrep.com/patent/US9902942B2

## CPC

- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- B01D 15/22: relating to the construction of the column
- B01D 15/34: Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
- B01D 15/362: {Cation-exchange}
- B01D 15/363: {Anion-exchange}
- B01D 15/3847: {Multimodal interactions}
- B01D 15/424: {Elution mode}
- B01D 61/145: {Ultrafiltration}
- C12N 2710/00051: Methods of production or purification of viral material
- C12N 2750/00051: Methods of production or purification of viral material
- C12N 2795/10151: Methods of production or purification of viral material
- C12N 2795/14151: Methods of production or purification of viral material
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)

## Abstract

A method of purifying a sample that includes a desired virus includes the steps of (i) providing a packed chromatographic column having negatively charged porous particles, (ii) equilibrating the column to the conditions to which the desired virus in the sample is to elute, (iii) contacting the sample with the packed chromatographic column such that the sample volume applied to the packed chromatographic column is less than or equal to the interparticle space of the negatively charged porous particles within the packed chromatographic column, (iv) eluting the desired virus from the packed chromatographic column, where the desired virus is in a purer state and in the conditions to which the packed chromatographic column was equilibrated.

## Claims

### Claim 1

A method of purifying a sample comprising a bacteriophage the method comprising the steps of:
(i) providing a packed chromatographic column comprising negatively charged porous particles wherein the particles have pores smaller in size than the bacteriophage;
(ii) equilibrating the packed chromatographic column with an equilibration buffer having a sufficient amount of salt, citrate or an acetate that yields a column conductivity in a range from 0.1 mS/cm to 30 mS/cm at a pH in a range from 5 to 7, wherein the bacteriophage does not substantially bind to the equilibrated packed chromatography column;
(iii) contacting the sample to the packed chromatographic column of (ii), wherein a sample volume applied consists of a volume that is less than or equal to a void volume of the negatively charged porous particles within the equilibrated packed chromatographic column; and
(iv) collecting a column effluent from the packed chromatographic column, wherein the column effluent comprises the bacteriophage in a more pure state compared to the sample applied in (iii) and, wherein the method does not use a column washing step or elution step.

### Claim 2 (depends on 1)

The method of claim 1, wherein the sample is unpurified, at an intermediate level of purity, highly purified, or concentrated.

### Claim 3 (depends on 1)

The method of claim 1, wherein the bacteriophage has been concentrated prior to its application to the column by ultrafiltration.

### Claim 4 (depends on 1)

The method of claim 1, wherein the sample has been previously exposed to a negatively charged surface or surfaces under conditions that provide a substantial absence of binding of the virus to the surface or surfaces prior to its application to the packed chromatographic column, and wherein the negatively charged surface or surfaces comprise a membrane, a monolith, a fiber or plurality of fibers, a particle or plurality of particles, or a compound construction thereof.

### Claim 5 (depends on 4)

The method of claim 4, wherein the negatively charged surface or surfaces further comprise secondary reactivities comprising the ability to participate in hydrophobic interactions, metal affinity interaction, or combinations thereof.

### Claim 6 (depends on 1)

The method of claim 1, wherein the packed chromatographic column is packed solely with the negatively charged porous particles and the sample volume is less than 40% of a volume of the packed chromatographic column.

### Claim 7 (depends on 1)

The method of claim 1, wherein the equilibration buffer has a pH in a range of from about 4 to about 7, or from about 4.5 to about 6.0.

### Claim 8 (depends on 1)

The method of claim 1, wherein the equilibration buffer comprises a conductivity value in a range of from about 0.1 mS/cm to about 15 mS/cm.

### Claim 9 (depends on 1)

The method of claim 1, wherein the sample comprises a sample application condition for contacting the sample with the packed chromatographic column, the sample application condition comprising a pH in a range from about 2 to about 10, or a range of conductivity from a non-zero conductivity up to a conductivity corresponding to a saturated solution of a particular salt or combination of salts.

### Claim 10 (depends on 1)

The method of claim 1, wherein the negatively charged porous particles comprise cation exchange particles, wherein electronegativity is optionally conferred to the negatively charged porous particles partly by a moiety selected from the group consisting of a carboxyl, a sulfa, or a phosphor moiety.

### Claim 11 (depends on 1)

The methods of claim 1, wherein the negatively charged porous particles comprise one or more secondary chemical functionalities selected from the group consisting of anion exchange, hydrophobic interactions, hydrogen bonding, pi-pi interactions, and metal chelation.

### Claim 12 (depends on 1)

The method of claim 1, comprising the additional step of contacting the sample with one or more contaminant-dissociating agents prior to the step of contacting the sample with the packed chromatographic column.

### Claim 13 (depends on 12)

The method of claim 12, wherein the one or more contaminant-dissociating agents are selected from the group consisting of salts, nonionic organic polymers, organic solvents, surfactants, and chaotropes.

### Claim 14 (depends on 13)

The method of claim 13, wherein the one or more contaminant-dissociating agents comprise a nonionic organic polymer selected from the group consisting of polyethylene glycol, polypropylene glycol and polybutylene glycol.

### Claim 15 (depends on 14)

The method of claim 14, wherein the nonionic organic polymer has an average molecular weight in a range from about 130 D to about 1000 D.

### Claim 16 (depends on 13)

The method of claim 13, wherein the one or more contaminant-dissociating agents comprise an organic solvent selected from the group consisting of ethylene glycol, propylene glycol, butylene glycol, dimethylsulfoxide, ethanol, and phenoxyethanol.

### Claim 17 (depends on 12)

The method of claim 12, wherein the one or more contaminant-dissociating agents are provided at a concentration range from about 0.01% to about 25% weight/volume.

### Claim 18 (depends on 13)

The method of claim 13, wherein the one or more contaminant-dissociating agents comprise a surfactant selected from the group consisting of Tween, triton, CHAPS, CHAPSO and octyl glucoside, wherein the surfactant is provided at a concentration range from about 0.001% to about 1% weight/volume or from about 0.001% to about 0.1% weight/volume.
